A New Arylpiperazine Antipsychotic (IV) with High D2/D3/5-HT1A/α 1A-Adrenergic Affinity and a Low Potential for Extrapyramidal Effects.
暂无分享,去创建一个
M. Renzi | R. Shank | A. Reitz | C. Maryanoff | D. J. Bennett | M. Scott | J. L. Vaught | E. Codd | P. Blum | M. E. Ortegón